Gilead Sciences Inc. Share Price Today: Live Updates & Key Insights
Gilead Sciences Inc. share price today is $129.96, up -1.18%. The stock opened at $131.125 against the previous close of $130.86, with an intraday high of $131.6525 and low of $129.04.
Gilead Sciences Inc. Share Price Chart
Gilead Sciences Inc.
Gilead Sciences Inc. Share Price Performance
Gilead Sciences Inc. Institutional Holdings
Gilead Sciences Inc. Market Status
Gilead Sciences Inc. Fundamentals
Market Cap 162471.84 M
PB Ratio 6.8818
PE Ratio 17.7317
Enterprise Value 176357.22 M
Total Assets 59023.00 M
Volume 5529741
Gilead Sciences Inc. Company Financials
About Gilead Sciences Inc. & investment objective
Company Information Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.
Organisation Drug Manufacturers - General
Employees 17000
Industry Drug Manufacturers - General
CEO Mr. Daniel Patrick O'Day
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Gilead Sciences Inc. FAQs
What is the share price of Gilead Sciences Inc. today?
The current share price of Gilead Sciences Inc. is $129.96.
Can I buy Gilead Sciences Inc. shares in India?
Yes, Indian investors can buy Gilead Sciences Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Gilead Sciences Inc. shares in India?
You can easily invest in Gilead Sciences Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Gilead Sciences Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Gilead Sciences Inc..
Can I buy fractional shares of Gilead Sciences Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Gilead Sciences Inc.?
Gilead Sciences Inc. has a market cap of $162471.84 M.
In which sector does Gilead Sciences Inc. belong?
Gilead Sciences Inc. operates in the Drug Manufacturers - General sector.
What documents are required to invest in Gilead Sciences Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Gilead Sciences Inc.?
The PE ratio of Gilead Sciences Inc. is 17.73 and the PB ratio is 6.88.